Real-time Stock quotes, portfolio, LIVE TV and more.
|
Aug 03, 2012, 01.09 PM IST
Ranbaxy Enter into in-Licensing agreement with Gilead Sciences
Ranbaxy Laboratories Ltd has informed BSE regarding a Press Release dated August 03, 2012 titled " Ranbaxy Enter into an In-Licensing Agreement with Gilead Sciences to Promote Access to Reduced Cost Generic Emtricitabine And Emtricitabine-Containing Fixed-Dose Antiretrovirals in Developing Countries".Source : BSE
Read all announcements in Ranbaxy Labs
Set email alert for |
News Videos
|